Cipta Sarana Medika Tbk. vs Saraswanti Anugerah Makmur Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Saraswanti Anugerah Makmur Tbk. trades at Rp278 (market cap 2.89T, 41.9K 24h volume). The key difference: Saraswanti Anugerah Makmur Tbk. is far larger — about 18.3× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 41.9K). Which is the better fit depends on your goals.
| DKHH | SAMF | |
|---|---|---|
Market Cap | 158.12B | 2.89T |
Volume | 8.21M | 41.9K |
Lot | 82.15K | 419 |
Turnover | 515.2M | 11.62M |
Average Price | 62.72 | 277.24 |
Value | 515.2M | 11.62M |
Indicative Equilibrium Price | 63 | 278 |
Indicative Equilibrium Volume | 1.33K | 30 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT. Saraswanti Anugerah Makmur Tbk. (the Company) was established based on the Notarial Deed of Titiek Lintang Trenggonowati, S.H., No.15 dated June 18, 1998, notary in Surabaya.
Read more on SAMF →